|
|
| MRD / Regn No. |
: SG1243 |
Date |
: 30/06/2026 |
| Patient Name |
: Balbir Kaur |
Age & Gender |
: 74 Yrs. / Female |
| Contact No. |
: 9674337066 |
UHID |
: |
| Ht / Wt / BMI |
: 157 / 58 / 23.53 |
BP S / BP D |
: 124 / 65 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (11/Apr/2020) | HYPERTENSION (11/Apr/2023) | CVA (11/Apr/2023) | IHD (11/Apr/2023) | HFMREF (30/Jan/2025) | PTCA (27/Mar/2025) | |
|
Plan |
: |
CONTINUE OTHER MEDICINES BY CARDIOLOGIST |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 106 mg/dL | HB HEMOGLOBIN: 11.7 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 5.9 % | MICROALBUMIN CREATININE RATIO: 10.01 mcg/mg | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
SEMAGLITIDE RYBELSUS 7 MG |
PO |
1-0-0 |
30 MINUTES BEFORE FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 30/Dec/2026 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE |
| |
|
| |
|